<code id='C31FC3F091'></code><style id='C31FC3F091'></style>
    • <acronym id='C31FC3F091'></acronym>
      <center id='C31FC3F091'><center id='C31FC3F091'><tfoot id='C31FC3F091'></tfoot></center><abbr id='C31FC3F091'><dir id='C31FC3F091'><tfoot id='C31FC3F091'></tfoot><noframes id='C31FC3F091'>

    • <optgroup id='C31FC3F091'><strike id='C31FC3F091'><sup id='C31FC3F091'></sup></strike><code id='C31FC3F091'></code></optgroup>
        1. <b id='C31FC3F091'><label id='C31FC3F091'><select id='C31FC3F091'><dt id='C31FC3F091'><span id='C31FC3F091'></span></dt></select></label></b><u id='C31FC3F091'></u>
          <i id='C31FC3F091'><strike id='C31FC3F091'><tt id='C31FC3F091'><pre id='C31FC3F091'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:79
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Public funding for King Charles III and royals has been recalculated due to windfarm deal profits
          Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

          Britain'sKingCharlesIIIandQueenCamilla,hidden,withallamaduringavisittoTheatrBrycheinioginBrecon,Wale

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Hospitals struggle to profit from CAR

          MedicaregenerallypaysfarmoreforCAR-Tdrugsthatareadministeredinoutpatientdepartmentsthanitdoesforinpa